Article Figures & Data
Figures
- Figure 1.
Efficacy: ACR Responses in Last 3 Months of ORAL Standard and First 3 Months of ORAL Sequel Study
Reproduced with permission from M Genovese, MD.
- Figure 2.
Safety: Incidence Rates per 100 Patient-Years
Reproduced with permission from M Genovese, MD.
Tools
Efficacy Maintained When Transitioning Directly from TNF Inhibitor to Tofacitinib in RA
Permalink:
Table of contents
Cited By...
- No citing articles found.